Management of Leukemoid Reaction
Initial Management
- Aggressive hydration is the first-line intervention for all patients with leukemoid reaction, with intravenous hydration at 2.5-3 liters/m²/day recommended, particularly in patients with hyperleukocytosis, according to Praxis Medical Insights 1
- Rehydration alone may help normalize white blood cell counts in dehydration-induced cases, as stated by Praxis Medical Insights 1
Management of Hyperleukocytosis
- For WBC counts >100,000/μL with symptoms of leukostasis, immediate medical treatment is required, and consider hydroxyurea at dosages up to 50-60 mg/kg per day until WBC decreases to <10-20 × 10⁹/L, as recommended by the guidelines cited in Blood 2
- Leukapheresis may be considered for initial management of hyperleukocytosis, though its impact on long-term outcomes is not established, according to Blood 2
Prevention of Complications
- Monitor for and prevent tumor lysis syndrome in cases of malignancy-associated leukemoid reaction by ensuring adequate hydration, controlling uric acid production using allopurinol or rasburicase, and monitoring urine pH, as stated in Blood 2
- Avoid excessive red blood cell transfusions until WBC has been reduced, as this can increase blood viscosity, according to Blood 2
Supportive Care
- Transfusion support may be required, with maintenance of hemoglobin above 8 g/dL and platelet transfusions if count falls below 10 × 10⁹/L or if there is active bleeding, as recommended by Blood 3
Special Considerations
- In pregnant patients with leukemoid reaction, management should be coordinated between hematologists, obstetricians, and neonatologists, as stated in Blood 4